Infection Surveillance Solutions Market: By Service Type, By Deployment Mode, By Application, Blood Stream Infections, Surgical Site Infections, Others), By End User, and Region Forecast 2019 - 2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Infection Surveillance Solutions Market Size, Share, Growth, Trends, and Global Industry Analysis: By Service Type (Product Support and Maintenance Services, Implementation Services, Training and Consulting Services, Software Services), By Deployment Mode (Web-based, On-premise), By Application (Urinary Tract Infections (UTI), Blood Stream Infections, Surgical Site Infections, Others), By End User (Hospitals, Long-term Care Facilities, Others), and Region Forecast 2019 - 2030

checked icon arrow_drop_down
checked icon Single User License $4400
checked icon Multiple User License $6600
checked icon Corporate User License $8900

Infection Surveillance Solutions Market size was valued at US$ 1,972.4 million in 2023 and grew at a CAGR of 16.7% from 2024 to 2030. The global market provides a detailed overview and that can be segmented by service type, by deployment mode, by application, and by end user. By service type, the market growth has been segmented into product Support and Maintenance Services, Implementation Services, Training and Consulting Services, and Software Services.

The Software Services segment is likely to be the largest and fastest-growing segment in terms of service type. The rise of this segment is mainly due to the growing frequency of hospital-acquired infections owing to the growing number of hospital admissions. The infection surveillance software solutions retain a track and record of the occurrence connected to hospital-acquired infections and aid healthcare providers in taking actions to monitor the infection spread. Based on deployment mode, the market is segmented into Web-based and on-premise. Among these, the Web-based deployment mode segment is expected to have the fastest-growing market during the forecast period.

The development of this market is mainly credited to its advantages to on-premise software solutions. Web-based software solutions are cost-effective when compared with on- premise-based; they achieve real-time analysis of data and are the most extensively accepted infection surveillance solutions for national level surveillance. Based on the Application, the market is segmented into Urinary Tract Infections (UTI), Blood Stream Infections, Surgical Site Infections, and Others. The Urinary Tract Infections (UTI) segment is expected to have a significant share in 2021. Based on the end user, the market is segmented into Hospitals, Long-term Care Facilities, and Others.

Infection Surveillance Solutions Market Key Development

  • In July 2021, BoxBoat (US) was acquired by IBM Corporation (US) to enhance IBM's container approach and application services portfolio.
  • In June 2021, bioMrieux SA (France) launched EPISEQ SARS-CoV-2 which is a cloud-based surveillance software application used to recognize variants using samples from patients who are positive

summary download arrow Download Free Sample

Global Infection Surveillance Solutions Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16.7%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America

Infection Surveillance Solutions Market Dynamics

The rise in the prevalence of HAIs, and the increase in the number of surgeries are anticipated to propel the market growth over the forecast years. Moreover, the overview of government protocols for inhibiting HAIs and growth in global healthcare spending is burgeoning the market growth over the forecast years.

Global Infection Surveillance Solutions Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 1,972.4 million

Market CAGR

16.7%

By Service Type

  • Product Support and Maintenance Services
  • Implementation Services
  • Training and Consulting Services
  • Software Services

By Deployment Model

  • Web-based
  • On-Premise

By Application

  • Urinary Tract Infections (UTI)
  • Blood Stream Infections
  • Surgical Site Infections
  • Others

By End User

  • Hospitals
  • Long-term Care Facilities
  • Others

Key Features of the Report

  • The infection surveillance solutions market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market.
     

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global infection surveillance solutions market was valued at US$ 1,972.4 million in 2023 and is projected to grow at a CAGR of 16.7% from 2024 to 2030.

The market key players are: Becton, Dickinson and Company (U.S.) Merck and Co., Inc. (U.S.) Premier Inc. (U.S.) Wolters Kluwer N.V. (Netherlands,), Baxter International Inc. (U.S.) GOJO Industries, Inc. (U.S.) Atlas Medical Software (U.S.) Deb Group Ltd (U.K.) Hygreen Inc. (U.S.) RL Solutions (Canada) TRUVEN Health Analytics (U.S.)

Technological developments in IT sectors causing the development of fully automatic diagnostic surveillance solution systems with the use of electronic medical records provides

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Infection Surveillance Solutions Market Introduction 
2.1.Global Infection Surveillance Solutions Market  - Taxonomy
2.2.Global Infection Surveillance Solutions Market  - Definitions
2.2.1.Service Type
2.2.2.Deployment Model
2.2.3.Application
2.2.4. End User
2.2.5.Region
3. Global Infection Surveillance Solutions Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Infection Surveillance Solutions Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Infection Surveillance Solutions Market  By Service Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Product Support and Maintenance Services
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Implementation Services
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Training and Consulting Services
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Software Services
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Infection Surveillance Solutions Market  By Deployment Model, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Web-based
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. On-Premise
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Infection Surveillance Solutions Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Urinary Tract Infections (UTI)
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Blood Stream Infections
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Surgical Site Infections
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Infection Surveillance Solutions Market  By  End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Long-term Care Facilities
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Others
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Infection Surveillance Solutions Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Infection Surveillance Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Service Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Product Support and Maintenance Services
10.1.2.Implementation Services
10.1.3.Training and Consulting Services
10.1.4.Software Services
10.2.  Deployment Model Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Web-based
10.2.2.On-Premise
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Urinary Tract Infections (UTI)
10.3.2.Blood Stream Infections
10.3.3.Surgical Site Infections
10.3.4.Others
10.4.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Long-term Care Facilities
10.4.3.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Infection Surveillance Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Product Support and Maintenance Services
11.1.2.Implementation Services
11.1.3.Training and Consulting Services
11.1.4.Software Services
11.2.  Deployment Model Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Web-based
11.2.2.On-Premise
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Urinary Tract Infections (UTI)
11.3.2.Blood Stream Infections
11.3.3.Surgical Site Infections
11.3.4.Others
11.4.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Long-term Care Facilities
11.4.3.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Infection Surveillance Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Product Support and Maintenance Services
12.1.2.Implementation Services
12.1.3.Training and Consulting Services
12.1.4.Software Services
12.2.  Deployment Model Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Web-based
12.2.2.On-Premise
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Urinary Tract Infections (UTI)
12.3.2.Blood Stream Infections
12.3.3.Surgical Site Infections
12.3.4.Others
12.4.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Long-term Care Facilities
12.4.3.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Infection Surveillance Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Product Support and Maintenance Services
13.1.2.Implementation Services
13.1.3.Training and Consulting Services
13.1.4.Software Services
13.2.  Deployment Model Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Web-based
13.2.2.On-Premise
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Urinary Tract Infections (UTI)
13.3.2.Blood Stream Infections
13.3.3.Surgical Site Infections
13.3.4.Others
13.4.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Long-term Care Facilities
13.4.3.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Infection Surveillance Solutions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Service Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Product Support and Maintenance Services
14.1.2.Implementation Services
14.1.3.Training and Consulting Services
14.1.4.Software Services
14.2.  Deployment Model Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Web-based
14.2.2.On-Premise
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Urinary Tract Infections (UTI)
14.3.2.Blood Stream Infections
14.3.3.Surgical Site Infections
14.3.4.Others
14.4.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Long-term Care Facilities
14.4.3.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Becton, Dickinson and Company (U.S.)
15.2.2.Merck and Co., Inc. (U.S.)
15.2.3.Premier Inc. (U.S.)
15.2.4.Wolters Kluwer N.V. (Netherlands,),
15.2.5.Baxter International Inc. (U.S.)
15.2.6.GOJO Industries, Inc. (U.S.)
15.2.7.Atlas Medical Software (U.S.)
15.2.8.Deb Group Ltd (U.K.)
15.2.9.Hygreen Inc. (U.S.)
15.2.10.RL Solutions (Canada)
15.2.11.TRUVEN Health Analytics (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Becton, Dickinson and Company (U.S.)
  • Merck and Co., Inc. (U.S.)
  • Premier Inc. (U.S.)
  • Wolters Kluwer N.V. (Netherlands,),
  • Baxter International Inc. (U.S.)
  • GOJO Industries, Inc. (U.S.)
  • Atlas Medical Software (U.S.)
  • Deb Group Ltd (U.K.)
  • Hygreen Inc. (U.S.)
  • RL Solutions (Canada)
  • TRUVEN Health Analytics (U.S.)

Related Industry Reports

Injection Molding Market

Hospital Furniture Market

Drug Discovery Market

Hormone Replacement Therapy Market